Associations of EPHB1 polymorphisms with hepatocellular carcinoma in the Korean population

被引:8
|
作者
Kim, Su Kang [2 ]
Jeon, Jung Won [1 ]
Park, Jae Jun [1 ]
Cha, Jae Myung [1 ]
Joo, Kwang Ro [1 ]
Lee, Joung Il [1 ]
Chung, Joo-Ho [2 ]
Shin, Dong-Hoon [3 ]
Shin, Hyun Phil [1 ]
机构
[1] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Seoul 134727, South Korea
[2] Kyung Hee Univ, Sch Med, Dept Pharmacol, Seoul 130701, South Korea
[3] Keimyung Univ, Sch Med, Dept Prevent Med, Taegu 704701, South Korea
关键词
Angiogenesis; Hepatocellular carcinoma; Polymorphism; EPHB1; RECEPTOR TYROSINE KINASES; COLORECTAL-CANCER; ANGIOGENESIS; LIGANDS; EPHRINS; LIVER;
D O I
10.1016/j.humimm.2011.06.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatocellular carcinoma (HCC) is a type of hypervascular tumor, and angiogenesis is important for HCC tumor growth. Eph receptor B1 (EPHB1), a member of the Eph family, mediates embryonic vascular system development and adult angiogenesis. This receptor may be involved in carcinogenesis of the digestive tract. Our aim was to examine the relationships between EPHBI polymorphisms and HCC in the Korean population. Genomic DNA was extracted from 182 patients with HCC and 266 healthy subjects. EPHB1 polymorphisms were determined by polymerase chain reaction and direct sequencing. Multiple logistic regression models (log-additive, dominant, and recessive models) were used for odds ratios, 95% confidence intervals, and p values. Five polymorphisms (rs11929692, rs7644369, rs6776570, rs3821502, and rs6766459) of the EPHB1 gene and alleles of 2 polymorphisms (rs1502174 and rs9877457) were associated with HCC (p < 0.05 for both). Our results suggest that EPHB1 polymorphisms may be associated with susceptibility to HCC in the Korean population. (C) 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:916 / 920
页数:5
相关论文
共 50 条
  • [1] The association between EPHB1 polymorphisms and the risk of hepatocellular Carcinoma (HCC) in South India
    Kumar, Ramesh Kumar Mithun
    Balachandar, V.
    Devi, S. Mohana
    Sasikala, K.
    Balamuralikrishnan, B.
    [J]. JOURNAL OF MEDICAL GENETICS, 2012, 49 : S52 - S52
  • [2] No associations of polymorphisms in ADPRT with hepatitis B virus clearance and hepatocellular carcinoma occurrence in a Korean population
    Lee, Jin Sol
    Kim, Jeong-Hyun
    Park, Byung-Lae
    Cheong, Hyun Sub
    Koh, InSong
    Kim, Jason Yong-ha
    Park, Tae Joon
    Pasaje, Charisse Flerida
    Bae, Joon Seol
    Lee, Hyo-Suk
    Kim, Yoon Jun
    Shin, Hyoung Doo
    [J]. HEPATOLOGY RESEARCH, 2011, 41 (03) : 250 - 257
  • [3] ASSOCIATION OF CANDIDATE GENES POLYMORPHISMS WITH HEPATOCELLULAR CARCINOMA IN KOREAN POPULATION
    Lee, Kyung In
    Seo, Hye Jin
    Kim, Yong Jin
    Park, Chang Wook
    Kim, Eun Soo
    Tang, Byoung Kuk
    Chung, Woo Jin
    Park, Kyung Sik
    Cho, Kwang Bum
    Hwang, Jaeseok
    Shin, Dong Hoon
    Yu, Kyung Im
    [J]. HEPATOLOGY, 2010, 52 (04) : 581A - 581A
  • [4] Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population
    Kim, Won Hee
    Min, Kyung Tae
    Jeon, Young Joo
    Kwon, Chang-Il
    Ko, Kwang Hyun
    Park, Pil Won
    Hong, Sung Pyo
    Rim, Kyu Seong
    Kwon, Sung Won
    Hwang, Seong Gyu
    Kim, Nam Keun
    [J]. GENE, 2012, 504 (01) : 92 - 97
  • [5] MATRIX METALLOPROTEINASE 1 GENE SINGLE NUCLEOTIDE POLYMORPHISMS ARE ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN KOREAN POPULATION
    Jang, B. K.
    Lee, J. E.
    Kim, K. H.
    Kim, S. J.
    Chung, W. J.
    Park, K. S.
    Cho, K. B.
    Yu, K. I.
    Shin, D. H.
    Hwang, J. S.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S194 - S194
  • [6] Associations of TERT polymorphisms with hepatocellular carcinoma risk in a Han Chinese population
    Zhang, Yingai
    Wang, Shunlan
    Shi, Yuting
    Cao, Yufang
    He, Haowei
    Zhou, Shuai
    Luo, Siqin
    Wen, Xiaohong
    Chen, Yang
    Liu, Haifang
    Xiao, Jingchuan
    Zhang, Shufang
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (07): : 7776 - 7783
  • [7] Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis
    Wang, Jian-dong
    Dong, Ying-chun
    Sheng, Zhen
    Ma, Heng-hui
    Li, Guo-li
    Wang, Xu-lin
    Lu, Guang-ming
    Sugimura, Haruhiko
    Jin, Jie
    Zhou, Xiao-jun
    [J]. ONCOLOGY, 2007, 73 (3-4) : 238 - 245
  • [8] Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population
    Qi, Xiaosheng
    Sun, Xing
    Xu, Junming
    Wang, Zhaowen
    Zhang, Jinyan
    Peng, Zhihai
    [J]. TUMOR BIOLOGY, 2014, 35 (03) : 1757 - 1762
  • [9] Regulation of EphB1 expression by dopamine signaling
    Halladay, AK
    Yue, Y
    Michna, L
    Widmer, DAJ
    Wagner, GC
    Zhou, R
    [J]. MOLECULAR BRAIN RESEARCH, 2000, 85 (1-2): : 171 - 178
  • [10] NOVEL ANTAGONIST TARGETING EPHB1 RECEPTOR
    Vaca, G.
    Bedini, A.
    Tolomelli, A.
    Spampinato, S.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 86 - 86